Jennifer L Taubert
CIK 1745938 · EVP, WWC. Innovative Medicine · last filed 2026-08-18
Jennifer L Taubert is an EVP, WWC. Innovative Medicine who has filed 40 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for JNJ, was dated Aug 18, 2026. Across all open-market trades the lifetime net is −$36.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $56.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$56.55M
3
40
-$36.87M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JNJ | EVP, WWC. Innovative Medicine | 209,451 | $270.00 | $56.55M | -$17.55M | 12 | 2026-08-18 |
| MCD | Director | — | $266.93 | — | $0 | 14 | 2026-07-02 |
| JOHNSON & JOHNSON (JNJ.WD) Delisted | EVP, WWC. Innovative Medicine | 194,451 | — | — | -$19.32M | 11 | 2026-02-18 |
Recent Filings
40 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-18 | JNJ | Mixed | — | -$2.22M | EDGAR |
| 2026-08-17 | JNJ | Notice (144) | −15,000 | -$3.95M | EDGAR |
| 2026-07-02 | MCD | Grant (A) | — | $0 | EDGAR |
| 2026-02-18 | JOHNSON & JOHNSON (JNJ.WD) Delisted | Mixed | +16,438 | -$3.84M | EDGAR |
| 2026-02-11 | JOHNSON & JOHNSON (JNJ.WD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2026-01-05 | MCD | Grant (A) | — | $0 | EDGAR |
| 2025-10-01 | MCD | Grant (A) | — | $0 | EDGAR |
| 2025-09-05 | JOHNSON & JOHNSON (JNJ.WD) Delisted | Mixed | — | -$4.29M | EDGAR |
| 2025-09-04 | JNJ | Notice (144) | −56,471 | -$10.04M | EDGAR |
| 2025-07-01 | MCD | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.